...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM?

Another rush of IPOs on tap for 2021 after a year of impressive pandemic offering!

Published: Dec. 24, 2020 at 8:45 a.m. ET

 

Despite COVID-19 and its economic effects, IPOs raised $150 billion in their best year since the dot-com-boom era.

It is typical for companies to delay their initial public offerings when the market for them is weak, but the unprecedented year that is 2020 is ending with companies delaying IPOs because the market is too strong.

More than 20 companies raked in at least $1 billion through their offerings in 2020.

https://www.marketwatch.com/story/another-rush-of-ipos-on-tap-for-2021-after-a-year-of-impressive-pandemic-offerings-11608773192?mod=home-page

 

Share
New Message
Please login to post a reply